Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Peak Bio Inc (PKBO)

Peak Bio Inc (PKBO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 1,619
  • Shares Outstanding, K 23,125
  • Annual Sales, $ 370 K
  • Annual Income, $ -12,830 K
  • EBIT $ -8 M
  • EBITDA $ -8 M
  • 60-Month Beta 1.56
  • Price/Sales 3.14
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.41
  • Most Recent Earnings $-0.09 on 08/23/24
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0230 +204.35%
on 10/14/24
0.1800 -61.11%
on 09/20/24
+0.0485 (+225.58%)
since 09/17/24
3-Month
0.0025 +2,700.00%
on 08/20/24
0.1800 -61.11%
on 09/20/24
+0.0604 (+629.17%)
since 06/25/24
52-Week
0.0020 +3,400.00%
on 03/01/24
0.2647 -73.55%
on 01/02/24
-0.0450 (-39.13%)
since 10/17/23

Most Recent Stories

More News
Akari Therapeutics Announces Effectiveness of Form S-4 and General Meeting Date of November 7, 2024 Related to Peak Bio Merger

AKTX : 2.36 (+4.16%)
PKBO : 0.0700 (+40.00%)
Peak Bio, Inc. Announces Closing of up to $100 Million Common Stock Purchase Transaction with White Lion Capital

Peak Bio, Inc. ("Peak Bio" or the "Company") (NASDAQ: PKBO), a clinical-stage biopharmaceutical company focused on developing the next-generation of therapeutics to treat oncology and inflammatory diseases,...

PKBO : 0.0700 (+40.00%)

Business Summary

Peak Bio Co., Ltd. is a clinical-stage biopharmaceutical company focused on developing therapeutics addressing significant unmet needs in the areas of oncology and inflammation. The company's lead product candidate includes PHP-303. Peak Bio Co., Ltd., formerly known as Ignyte Acquisition Corp., is based...

See More

Key Turning Points

3rd Resistance Point 0.0967
2nd Resistance Point 0.0833
1st Resistance Point 0.0767
Last Price 0.0700
1st Support Level 0.0567
2nd Support Level 0.0433
3rd Support Level 0.0367

See More

52-Week High 0.2647
Fibonacci 61.8% 0.1643
Fibonacci 50% 0.1333
Fibonacci 38.2% 0.1024
Last Price 0.0700
52-Week Low 0.0020

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar